Paula Jimenez-Fonseca

58PUBLICATIONS
171CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPacific Peoples research methodsMolecular targetsPersonality and individual differences
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Jul 14, 2026
Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment.

|Jun 26, 2026
Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.

|Apr 28, 2026
Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain.

|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca

|Dec 11, 2025
Measurement properties of the Spanish version of assessment of survivor concerns in cancer patients.

Caterina Calderon, Urbano Lorenzo-Seva, Pere J Ferrando

|Sep 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo

Pageof 10

Frequent Collaborators

21 joint publications

Caterina Calderon

19 joint publications

Alberto Carmona-Bayonas

14 joint publications

Raquel Hernández-San Gil

13 joint publications

Ana Fernandez-Montes